Search Results for "SREBF1c" - 171 interactions found in 73 entries.

123Next
Entry-ID
Interactor1 (Subject) Interaction type Interactor2 (Object) additional information
PubMed-ID
Diseases
171
690 female pattern of growth hormone expression NOT affects_expression of SREBF1c in liver
15280151 Diabetes mellitus, type II
Insulin resistance
276
1122 Insulin increases_activity of SREBF1c
1127 SREBF1c increases_activity of GCK
1132 SREBF1c affects_activity of lipid biosynthetic process in liver
10535992 Diabetes mellitus, type II
Insulin resistance
281
1137 Insulin increases_quantity of SREBF1c in liver; in streptozotocin-diabetic rats
1139 Streptozocin decreases_expression of SREBF1c
10570128 Diabetes mellitus, type II
Insulin resistance
282
1176 Insulin increases_expression of SREBF1c
1177 Glucagon decreases_expression of SREBF1c
1178 Glucose increases_quantity of SREBF1c
1180 SREBF1c increases_quantity of Pyruvate kinase
1182 SREBF1c increases_quantity of FASN
1183 SREBF1c increases_quantity of THRSP
1184 SREBF1c increases_quantity of ACACB
1185 SREBF1c affects_activity of lipid biosynthetic process
10207099 Diabetes mellitus, type II
Insulin resistance
315
1249 IRS2 NOT affects_expression of SREBF1c after insulin-stimulation
10949029 Diabetes mellitus, type II
Insulin resistance
319
1262 SREBF1c increases_expression of GCK
1263 SREBF1c decreases_expression of PCK
11679417 Diabetes mellitus, type II
Insulin resistance
321
1267 SREBF1c decreases_expression of PCK1
11443121 Diabetes mellitus, type II
Insulin resistance
330
1285 ob/ob mouse increases_quantity of SREBF1c
1286 SREBF1c increases_activity of fatty acid biosynthetic process in liver
1295 aP2-SREBP-1c436 mouse increases_quantity of SREBF1c
10514488 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
346
1464 AMPK decreases_expression of SREBF1c in liver
11602624 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
368
1478 Insulin resistance increases_quantity of SREBF1c in liver; in obese mice
1500 HSPA5 affects_quantity of SREBF1c
19363290 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
369
1484 response to endoplasmic reticulum stress increases_quantity of SREBF1c in liver
19363290 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
578
3061 NR1H3 affects_expression of SREBF1c
3062 NR1H-RXR complex affects_expression of SREBF1c
12838 NR1H2 affects_expression of SREBF1c
11287605 Diabetes mellitus, type II
Insulin resistance
664
3679 SREBF1c increases_expression of FASN in liver
3684 Insulin affects_expression of SREBF1c
10940327 Diabetes mellitus, type II
Diabetes mellitus, type I
Insulin resistance
Hypothyroidism
732
4122 dietary fat affects_activity of SREBF1c in liver
16614395 Diabetes mellitus, type II
Insulin resistance
824
4933 NR1H increases_expression of SREBF1c
4969 high-saturated-fat diet increases_expression of SREBF1c in liver
45973 PPARGC1 affects_activity of SREBF1c
19770177 Diabetes mellitus, type II
Obesity
Insulin resistance
904
5382 SIRT1 affects_expression of SREBF1c in response to high-fat diet, if SIRT1 is overexpressed
18599449 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
1,205
8086 CCL2 increases_expression of SREBF1c in liver; after chronic MCP-1 administration
20056828 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
1,519
10768 Polyunsaturated fatty acid, omega-3 NOT affects_expression of SREBF1c
19211925 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
1,958
15186 Obesity decreases_expression of SREBF1c in adipose tissue
15190 Insulin increases_expression of SREBF1c in skeletal muscle, in adipose tissue; in control subjects, in insulin-resistant nondiabetic obese patients, and in hyperglycemic type 1 diabetic subjects
15193 Insulin NOT increases_expression of SREBF1c in skeletal muscle, in adipose tissue; in type 2 diabetic patients
15200 Diabetes mellitus, type II affects_expression of SREBF1c in skeletal muscle, in adipose tissue; if induced by insulin
11334418 Diabetes mellitus, type II
Diabetes mellitus, type I
Obesity
Insulin resistance
2,228
18851 Coffee polyphenol decreases_expression of SREBF1c in liver
20943752 Diabetes mellitus, type II
Insulin resistance
2,696
25239 DUSP9 decreases_expression of SREBF1c in liver; in ob/ob mice
18296638 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
3,571
33406 NR1H4 affects_expression of SREBF1c in white adipose tissue
16446356 Diabetes mellitus, type II
Insulin resistance
3,622
34320 Triiodothyronine decreases_expression of SREBF1c in adipose tissue
34321 SREBF1c affects_activity of lipid biosynthetic process in adipose tissue
21941681 Diabetes mellitus, type II
Insulin resistance
Hypothyroidism
Hyperthyroidism
3,646
34621 NR1H4 decreases_expression of SREBF1c via NR0B2 activation
22187656 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
3,890
39307 insulin receptor signaling pathway affects_activity of SREBF1c in liver
39308 impaired insulin receptor signaling increases_activity of SREBF1c in liver
39309 SREBF1c increases_activity of lipid biosynthetic process in liver
39351 Polyunsaturated fatty acid, omega-3 decreases_activity of SREBF1c
22941588 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
Metabolic syndrome
3,912
39713 Persistent organic pollutant increases_expression of SREBF1c in liver
20064776 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
3,930
39906 Naringenin decreases_expression of SREBF1c in liver; in Ldlr-/- mice
39921 Naringenin decreases_quantity of SREBF1c in muscle; in Ldlr-/- mice
19592617 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
4,615
46183 Ethinylestradiol decreases_expression of SREBF1c in adrenal gland
46249 Dexamethasone decreases_expression of SREBF1c in adrenal gland
46262 cAMP increases_expression of SREBF1c in granulosa cells
24205079 Diabetes mellitus, type II
Insulin resistance
4,742
46924 Quercetin decreases_expression of SREBF1c in liver
46926 Allopurinol decreases_expression of SREBF1c in liver
23647015 Diabetes mellitus, type II
Diabetes mellitus, type I
Insulin resistance
Fatty liver disease, nonalcoholic
4,779
47301 SREBF1c affects_activity of Fatty liver disease, nonalcoholic
47302 SREBF1c NOT affects_activity of hyperglycemia after reversion of hepatic steatosis
47303 SREBF1c NOT affects_activity of increased circulating insulin level after reversion of hepatic steatosis
47304 SREBF1c NOT affects_activity of insulin receptor signaling pathway in liver; after reversion of hepatic steatosis
47305 SREBF1c NOT affects_phosphorylation of Insulin receptor in liver; after reversion of hepatic steatosis
47306 SREBF1c NOT affects_phosphorylation of IRS1 in liver; after reversion of hepatic steatosis
47307 SREBF1c NOT affects_phosphorylation of AKT1 in liver; after reversion of hepatic steatosis
47308 SREBF1c NOT affects_phosphorylation of FOXO1 in liver; after reversion of hepatic steatosis
47309 SREBF1c NOT affects_expression of TNF in liver; after reversion of hepatic steatosis
47310 SREBF1c NOT affects_expression of IL1B in liver; after reversion of hepatic steatosis
47311 SREBF1c NOT affects_expression of TLR2 in liver; after reversion of hepatic steatosis
47312 SREBF1c NOT affects_expression of MYD88 in liver; after reversion of hepatic steatosis
47313 SREBF1c NOT affects_phosphorylation of IKBKB in liver; after reversion of hepatic steatosis
47314 SREBF1c NOT affects_quantity of NF-kappaB complex in liver; after reversion of hepatic steatosis
47315 SREBF1c NOT affects_activity of Insulin resistance in liver; after reversion of hepatic steatosis
22932913 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
123Next
-->